wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33554356-C4CCB7C0-1686-46B7-875F-500FE0B2B5E7
Q33554356-C4CCB7C0-1686-46B7-875F-500FE0B2B5E7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33554356-C4CCB7C0-1686-46B7-875F-500FE0B2B5E7
The use of tumour necrosis factor alpha-blockers in daily routine. An Austrian consensus project.
P2860
Q33554356-C4CCB7C0-1686-46B7-875F-500FE0B2B5E7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33554356-C4CCB7C0-1686-46B7-875F-500FE0B2B5E7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b639f98356d80180d99a778ae04ec83384e715b4
P2860
The Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT): results of radiographic analyses after 1 year.